ArticleTherapeutic advances in musculoskeletal disease2026
Cardiovascular safety of romosozumab versus denosumab for osteoporosis treatment: a multinational real-world data analysis.
Balqis Istiqomah Gusbela et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.